"PJS secara rasminya beroperasi pada 1 Januari 2011 dengan sewaan minima dari SIMC dengan kapasiti katil sebanyak 106 unit katil dan telah dirasmikan oleh Perdana Menteri pada 16 Januari 2011. Antara jabatan awal yang beroperasi sepenuhnya di PJS adalah Jabatan Kardiologi, Jabatan Kardiotorasik dan Kardiak Anestisiologi & Perfusi. Pada 2012, Jabatan Geriatrik turut dipindahkan ke PJS. Manakala sebahagian jabatan seperti perkhidmatan Hemodialisis, Radioterapi & Onkologi, Urologi serta perkhidmatan sokongan lain seperti Patologi, Radiologi, Dietatik, Fisioterapi dan lain-lain turut beroperasi di PJS. PJS beroperasi sepenuhnya sebagai jabatan berasingan dari Hospital Umum Sarawak bermula Julai 2016."

During the past decade, Sarawak Heart Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sarawak Heart Centre" #1 sponsor was "Bayer" with 3 trials, followed by "Actelion" with 2 trials sponsored, "InnoRa GmbH" with 1 trials sponsored, "Medtronic Bakken Research Center" with 1 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sarawak Heart Centre" #1 collaborator was "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator, "Medtronic Japan Co., Ltd." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Sarawak Heart Centre" are "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials) and "Heart Failure NYHA Class II" (1 trials). Many other conditions were trialed in "Sarawak Heart Centre" in a lesser frequency.

Most popular intervention types in "Sarawak Heart Centre" are "Drug" (5 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Macitentan 10 mg" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sarawak Heart Centre" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Sarawak Heart Centre". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Sarawak Heart Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sarawak Heart Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".